Multiple Myeloma — Year in Review Series on Relevant New Datasets and Advances
Hematologic Oncology Update
00:00
Advancements in Multiple Myeloma Treatment
This chapter explores the efficacy of belantamab in treating multiple myeloma, particularly in resistant patient populations, while addressing concerns about its ophthalmic toxicity. The discussion includes insights from pivotal studies and highlights the importance of careful monitoring and innovative treatment approaches, including novel CAR-T agents.
Transcript
Play full episode
